These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 709555

  • 1. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
    Johnson RK, Chitnis MP, Embrey WM, Gregory EB.
    Cancer Treat Rep; 1978 Oct; 62(10):1535-47. PubMed ID: 709555
    [Abstract] [Full Text] [Related]

  • 2. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ, Wang H, Blair GW.
    Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
    [Abstract] [Full Text] [Related]

  • 3. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E, Menconi E, Barzi AM.
    Boll Soc Ital Biol Sper; 1984 Jul 31; 60(7):1369-75. PubMed ID: 6477749
    [Abstract] [Full Text] [Related]

  • 4. Differential effect of collaterally sensitive antimetabolites on P388 murine leukemia sensitive and resistant to adriamycin in vitro.
    Satyamoorthy K, Deshpande SS, Chitnis MP.
    Neoplasma; 1989 Jul 31; 36(6):673-83. PubMed ID: 2515459
    [Abstract] [Full Text] [Related]

  • 5. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ.
    Cancer Res; 1988 Jul 01; 48(13):3595-602. PubMed ID: 2897875
    [Abstract] [Full Text] [Related]

  • 6. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D, Wilberding C.
    Cancer Res; 1985 Apr 01; 45(4):1687-91. PubMed ID: 3919944
    [Abstract] [Full Text] [Related]

  • 7. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
    Inaba M, Kobayashi H, Sakurai Y, Johnson RK.
    Cancer Res; 1979 Jun 01; 39(6 Pt 1):2200-3. PubMed ID: 445418
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
    Ramu N, Ramu A, Cole DE, Balis FM, Poplack DG, Pollard HB.
    Isr J Med Sci; 1988 Jun 01; 24(9-10):477-82. PubMed ID: 2974448
    [Abstract] [Full Text] [Related]

  • 9. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A, Fuks Z, Gatt S, Glaubiger D.
    Cancer Res; 1984 Jan 01; 44(1):144-8. PubMed ID: 6690032
    [Abstract] [Full Text] [Related]

  • 10. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.
    Ganapathi R, Reiter W, Krishan A.
    J Natl Cancer Inst; 1982 Jun 01; 68(6):1027-32. PubMed ID: 6953267
    [Abstract] [Full Text] [Related]

  • 11. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK, Chitnis MP.
    Neoplasma; 1990 Jun 01; 37(1):31-6. PubMed ID: 2320178
    [Abstract] [Full Text] [Related]

  • 12. Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).
    Johnson RK, Ovejera AA, Goldin A.
    Cancer Treat Rep; 1976 Jan 01; 60(1):99-102. PubMed ID: 826316
    [No Abstract] [Full Text] [Related]

  • 13. Biochemical parameters of resistance of an adriamycin-resistant subline of P388 leukemia to emetine, an inhibitor of protein synthesis.
    Chitnis MP, Johnson RK.
    J Natl Cancer Inst; 1978 May 01; 60(5):1049-54. PubMed ID: 642026
    [Abstract] [Full Text] [Related]

  • 14. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
    Chandrasekaran B, Dimling J, Capizzi RL.
    Cancer Treat Rep; 1987 Feb 01; 71(2):195-6. PubMed ID: 2948640
    [Abstract] [Full Text] [Related]

  • 15. In vivo characterization of P388 leukemia resistant to mitomycin C.
    Rose WC, Huftalen JB, Bradner WT, Schurig JE.
    In Vivo; 1987 Feb 01; 1(1):47-52. PubMed ID: 2979764
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
    Ganapathi R, Grabowski D.
    Cancer Res; 1983 Aug 01; 43(8):3696-9. PubMed ID: 6861140
    [Abstract] [Full Text] [Related]

  • 17. Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D.
    Wilkoff LJ, Dulmadge EA.
    J Natl Cancer Inst; 1978 Dec 01; 61(6):1521-4. PubMed ID: 281559
    [Abstract] [Full Text] [Related]

  • 18. Exploring multidrug resistance using rhodamine 123.
    Kessel D.
    Cancer Commun; 1989 Dec 01; 1(3):145-9. PubMed ID: 2639727
    [Abstract] [Full Text] [Related]

  • 19. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
    Nori M, Gothoskar BP.
    Neoplasma; 1983 Dec 01; 30(3):287-93. PubMed ID: 6223231
    [Abstract] [Full Text] [Related]

  • 20. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD, Steinkampf RW, Havlick MJ, Jackson RC.
    Cancer Res; 1986 Sep 01; 46(9):4352-6. PubMed ID: 3460695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.